Performance verification of the Abbott SARS-CoV-2 test for qualitative detection of IgG in Cali, Colombia.

ABSTRACT:

Background

Adequate testing is critically important for control of the SARS-CoV-2 pandemic. Antibody testing is an option for case management and epidemiologic studies, with high specificity and variable sensitivity. However, characteristics of local populations may affect performance of these tests. For this reason, the National Institute of Health (INS) and regulatory agencies in Colombia require verification of diagnostic accuracy of tests introduced to the Colombian market.

Methods

We conducted a validation study of the Abbott SARS-CoV-2 test for qualitative detection of IgG using the Abbott Architect i2000SR. Participants and retrospective samples were included from patients with suspected SARS-CoV-2 infection, age ≥18 years, and ≥8 days elapsed since initiation of symp

SUBMITTER: Castro MDM 

PROVIDER: S-EPMC8409620 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature